Vericel (VCEL) EBT (2010 - 2026)
Vericel (VCEL) reported EBT of -$6.8 million for Q1 2026, up 41.85% on a YoY basis from -$4.8 million in Q1 2025, and down 128.33% sequentially from $24.1 million in Q4 2025.
Vericel (VCEL) EBT (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of EBT data on file, last reported at -$6.8 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 41.85% year-over-year to -$6.8 million; the trailing twelve-month figure through Mar 2026 stood at $20.9 million (up 874.67% YoY), and the FY2025 full-year result was $17.4 million, up 65.34% from the prior year.
- EBT retreated to -$6.8 million in Q1 2026, from $24.1 million in the prior quarter.
- In the past five years, EBT ranged from a high of $24.1 million in Q4 2025 to a low of -$55.9 million in Q2 2023.
- A 5-year average of -$3.0 million and a median of -$4.3 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT slumped 523.47% in 2023 and surged 614.21% in 2025, its largest moves.
- Tracing VCEL's EBT over 5 years: stood at $6.6 million in 2022, then soared by 112.82% to $14.1 million in 2023, then soared by 41.6% to $20.0 million in 2024, then grew by 20.96% to $24.1 million in 2025, then tumbled by 128.33% to -$6.8 million in 2026.
- Business Quant data shows VCEL's EBT at -$6.8 million in Q1 2026, $24.1 million in Q4 2025, and $4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -6.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.84 Mn |
| Dec 31, 2025 | 24.14 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | -997,000.00 |
| Mar 31, 2025 | -11.76 Mn |
| Dec 31, 2024 | 19.96 Mn |
| Sep 30, 2024 | -901,000.00 |
| Jun 30, 2024 | -5.15 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | 14.09 Mn |
| Sep 30, 2023 | -3.95 Mn |
| Jun 30, 2023 | -55.88 Mn |
| Mar 31, 2023 | -7.96 Mn |
| Dec 31, 2022 | 6.62 Mn |
| Sep 30, 2022 | -6.56 Mn |
| Jun 30, 2022 | -8.96 Mn |
| Mar 31, 2022 | -7.09 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Sep 30, 2021 | -4.93 Mn |
| Jun 30, 2021 | -3.71 Mn |